Role of liver transplantation in cancer therapy

S. Iwatsuki, R. D. Gordon, Byers Wendell Shaw Jr, T. E. Starzl

Research output: Contribution to journalArticle

371 Citations (Scopus)

Abstract

Fifty-four patients underwent total hepatectomy and liver replacement in the presence of a primary liver malignancy. in 13 recipients in whom the hepatic tumors were incidental to some other endstage liver disease, recurrence was not seen and 12 of the 13 patients are alive after 4 months to 15 1/2 years. In contrast, tumors recurred in 3 of every 4 patients who received liver replacement primarily because of hepatic malignancies that could not be resected by conventional techniques of subtotal hepatectomy and who lived for at least 2 months after transplantation. The most encouraging results were in patients with the fibrolamellar hepatocellular carcinomas that grow slowly and metastasize late, but even with this lesion, the recurrence rate was 57%. In future trials, additional effective anticancer therapy will be needed to improve the results of liver transplantation for primary liver malignancy, but what an improved strategy should be has not yet been defined.

Original languageEnglish (US)
Pages (from-to)401-407
Number of pages7
JournalAnnals of surgery
Volume202
Issue number4
DOIs
StatePublished - Jan 1 1985

Fingerprint

Liver Transplantation
Liver
Neoplasms
Hepatectomy
Therapeutics
Recurrence
Liver Diseases
Transplantation

ASJC Scopus subject areas

  • Surgery

Cite this

Iwatsuki, S., Gordon, R. D., Shaw Jr, B. W., & Starzl, T. E. (1985). Role of liver transplantation in cancer therapy. Annals of surgery, 202(4), 401-407. https://doi.org/10.1097/00000658-198510000-00001

Role of liver transplantation in cancer therapy. / Iwatsuki, S.; Gordon, R. D.; Shaw Jr, Byers Wendell; Starzl, T. E.

In: Annals of surgery, Vol. 202, No. 4, 01.01.1985, p. 401-407.

Research output: Contribution to journalArticle

Iwatsuki, S, Gordon, RD, Shaw Jr, BW & Starzl, TE 1985, 'Role of liver transplantation in cancer therapy', Annals of surgery, vol. 202, no. 4, pp. 401-407. https://doi.org/10.1097/00000658-198510000-00001
Iwatsuki S, Gordon RD, Shaw Jr BW, Starzl TE. Role of liver transplantation in cancer therapy. Annals of surgery. 1985 Jan 1;202(4):401-407. https://doi.org/10.1097/00000658-198510000-00001
Iwatsuki, S. ; Gordon, R. D. ; Shaw Jr, Byers Wendell ; Starzl, T. E. / Role of liver transplantation in cancer therapy. In: Annals of surgery. 1985 ; Vol. 202, No. 4. pp. 401-407.
@article{6b5ddcd4f0cf4402a5654e1a68bf4135,
title = "Role of liver transplantation in cancer therapy",
abstract = "Fifty-four patients underwent total hepatectomy and liver replacement in the presence of a primary liver malignancy. in 13 recipients in whom the hepatic tumors were incidental to some other endstage liver disease, recurrence was not seen and 12 of the 13 patients are alive after 4 months to 15 1/2 years. In contrast, tumors recurred in 3 of every 4 patients who received liver replacement primarily because of hepatic malignancies that could not be resected by conventional techniques of subtotal hepatectomy and who lived for at least 2 months after transplantation. The most encouraging results were in patients with the fibrolamellar hepatocellular carcinomas that grow slowly and metastasize late, but even with this lesion, the recurrence rate was 57{\%}. In future trials, additional effective anticancer therapy will be needed to improve the results of liver transplantation for primary liver malignancy, but what an improved strategy should be has not yet been defined.",
author = "S. Iwatsuki and Gordon, {R. D.} and {Shaw Jr}, {Byers Wendell} and Starzl, {T. E.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1097/00000658-198510000-00001",
language = "English (US)",
volume = "202",
pages = "401--407",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Role of liver transplantation in cancer therapy

AU - Iwatsuki, S.

AU - Gordon, R. D.

AU - Shaw Jr, Byers Wendell

AU - Starzl, T. E.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Fifty-four patients underwent total hepatectomy and liver replacement in the presence of a primary liver malignancy. in 13 recipients in whom the hepatic tumors were incidental to some other endstage liver disease, recurrence was not seen and 12 of the 13 patients are alive after 4 months to 15 1/2 years. In contrast, tumors recurred in 3 of every 4 patients who received liver replacement primarily because of hepatic malignancies that could not be resected by conventional techniques of subtotal hepatectomy and who lived for at least 2 months after transplantation. The most encouraging results were in patients with the fibrolamellar hepatocellular carcinomas that grow slowly and metastasize late, but even with this lesion, the recurrence rate was 57%. In future trials, additional effective anticancer therapy will be needed to improve the results of liver transplantation for primary liver malignancy, but what an improved strategy should be has not yet been defined.

AB - Fifty-four patients underwent total hepatectomy and liver replacement in the presence of a primary liver malignancy. in 13 recipients in whom the hepatic tumors were incidental to some other endstage liver disease, recurrence was not seen and 12 of the 13 patients are alive after 4 months to 15 1/2 years. In contrast, tumors recurred in 3 of every 4 patients who received liver replacement primarily because of hepatic malignancies that could not be resected by conventional techniques of subtotal hepatectomy and who lived for at least 2 months after transplantation. The most encouraging results were in patients with the fibrolamellar hepatocellular carcinomas that grow slowly and metastasize late, but even with this lesion, the recurrence rate was 57%. In future trials, additional effective anticancer therapy will be needed to improve the results of liver transplantation for primary liver malignancy, but what an improved strategy should be has not yet been defined.

UR - http://www.scopus.com/inward/record.url?scp=0022376733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022376733&partnerID=8YFLogxK

U2 - 10.1097/00000658-198510000-00001

DO - 10.1097/00000658-198510000-00001

M3 - Article

VL - 202

SP - 401

EP - 407

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 4

ER -